Beijing Kawin Technology Share-Holding Co., Ltd.
4 clinical trials · Sponsor
◉ Watch Beijing Kawin Technology Share-Holding Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection (NCT06544551) | Beijing Kawin Technology Share-Holding Co., Ltd. | 2021-12-28 |
| Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C (NCT01903278) | Beijing Kawin Technology Share-Holding Co., Ltd. | 2013-06-01 |
| A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C (NCT01908335) | Beijing Kawin Technology Share-Holding Co., Ltd. | 2012-10-01 |
| Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF) (NCT01504334) | Beijing Kawin Technology Share-Holding Co., Ltd. | 2012-01-01 |
Track Beijing Kawin Technology Share-Holding Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.